These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19356371

  • 1. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ, Lederer ED, Price BA, Yam LT.
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [Abstract] [Full Text] [Related]

  • 2. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK.
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [Abstract] [Full Text] [Related]

  • 3. Significance of serum TRACP in rheumatoid arthritis.
    Janckila AJ, Neustadt DH, Yam LT.
    J Bone Miner Res; 2008 Aug; 23(8):1287-95. PubMed ID: 18410226
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ, Takahashi K, Sun SZ, Yam LT.
    Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
    [Abstract] [Full Text] [Related]

  • 5. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 6. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT.
    Clin Chim Acta; 2002 Jun 01; 320(1-2):49-58. PubMed ID: 11983200
    [Abstract] [Full Text] [Related]

  • 7. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY, Lee SH, Chen MM, Neustadt DH, Chaudhry UA, Yam LT, Janckila AJ.
    Clin Chim Acta; 2005 Sep 01; 359(1-2):132-40. PubMed ID: 15993395
    [Abstract] [Full Text] [Related]

  • 8. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct 01; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 9. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ, Simons RM, Yam LT.
    Clin Chim Acta; 2004 Sep 01; 347(1-2):157-67. PubMed ID: 15313154
    [Abstract] [Full Text] [Related]

  • 10. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A.
    Bone; 2004 Jan 01; 34(1):187-94. PubMed ID: 14751577
    [Abstract] [Full Text] [Related]

  • 11. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
    Takahashi K, Janckila AJ, Sun SZ, Lederer ED, Ray PC, Yam LT.
    Clin Chim Acta; 2000 Nov 01; 301(1-2):147-58. PubMed ID: 11020469
    [Abstract] [Full Text] [Related]

  • 12. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb 01; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

  • 13. Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
    Janckila AJ, Nakasato YR, Neustadt DH, Yam LT.
    J Bone Miner Res; 2003 Oct 01; 18(10):1916-9. PubMed ID: 14584907
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 15. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients.
    Fujimori A, Okada S, Sakai M, Tome K, Fukagawa M.
    Nephron Clin Pract; 2011 Nov 15; 118(4):c375-9. PubMed ID: 21325869
    [Abstract] [Full Text] [Related]

  • 16. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Nov 15; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.
    J Pediatr Endocrinol Metab; 2005 Jan 15; 18(1):55-62. PubMed ID: 15679069
    [Abstract] [Full Text] [Related]

  • 18. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ.
    Osteoporos Int; 2005 Sep 15; 16(9):1109-16. PubMed ID: 15605190
    [Abstract] [Full Text] [Related]

  • 19. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug 15; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 20. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK.
    Clin Lab; 2006 Aug 15; 52(9-10):499-509. PubMed ID: 17078477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.